Shalabh Gupta became CEO of Unicycive Therapeutics, Inc. on July 7, 2025.
1 report, 0 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Shalabh Gupta became CEO of Unicycive Therapeutics, Inc. on July 7, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Unicycive Therapeutics, Inc.
Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications
Nothing else this week.
-
Shalabh Gupta
researcher
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet